I broke out in hives after severely burning out at my job — so I quit. I'm not willing to die for an early retirement.

Audrey Wang was so burned out from her job in high-end estate management that she broke out in hives that lasted six years.
GlobalData on MSN

Dupixent gains chronic spontaneous urticaria indication in Europe

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...

'I'm allergic to winter – I can't even walk down the freezer aisle in the supermarket'

EXCLUSIVE: Kirsten Evans suffers a severe reaction to cold exposure that makes every winter a living nightmare ...
Healio

Remibrutinib favorable despite past anti-IgE biologic use in chronic spontaneous urticaria

Among adults with chronic spontaneous urticaria inadequately controlled by H1 antihistamine treatment, remibrutinib improved ...

EU approves Sanofi and Regeneron’s Dupixent as first targeted therapy for chronic spontaneous urticaria in a decade

Sanofi ( SNY) and Regeneron’s ( REGN) Dupixent has gained EU approval as the first targeted therapy in more than ten years ...
The American Journal of Managed Care

Urticaria Symptoms, Sleep Improve With Remibrutinib: Mark Lebwohl, MD

Patients with chronic spontaneous urticaria (CSU) experienced improved quality of life and sleep when symptoms were mitigated ...
PharmiWeb

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

A simple prescription taken by 1 million Americans made my skin blister from head to toe - and my organs fail. Doctors say I'm the sickest patient that's ever lived

Christine Sentz's ordeal began with a simple prescription, but quickly escalated into a near-death medical crisis.

Samantha-Raj’s Wedding: How The Actress Battled Myositis While Building A New Life

Samantha’s wedding to Raj marks a new beginning after her battle with myositis. From treatment to lifestyle changes, she ...

Deutsche Bank Maintains a Buy Rating on Sanofi (SNY)

Sanofi (NASDAQ: SNY) is one of the best low volatility large cap stocks to invest in. Deutsche Bank analyst Emmanuel ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...